DIA 2018 Global Annual Meeting

The Economist Intelligence Unit will unveil its independent research findings titled, “The Innovation Imperative: The Future of Drug Development.” Commissioned by PAREXEL, the report shows how four key innovations consistently improve industry success metrics such as enrollment rates, regulatory approval, and payer adoption. However, despite their quantifiable positive impact, their adoption appears low. The reasons for this “adoption lag” and potential solutions will be discussed.